Great question! Aimovig (erenumab) is FDA-approved to help *prevent* migraine attacks in adults. It works by blocking CGRP, a protein that widens blood vessels and contributes to pain and inflammation during migraines.
However, the research and approval for Aimovig has primarily focused on migraine attacks in general, and Show Full Answer
Great question! Aimovig (erenumab) is FDA-approved to help *prevent* migraine attacks in adults. It works by blocking CGRP, a protein that widens blood vessels and contributes to pain and inflammation during migraines.
However, the research and approval for Aimovig has primarily focused on migraine attacks in general, and there isn't strong specific evidence addressing its effectiveness for aura symptoms that occur *without* a headache. Since aura-only episodes can be tricky to treat, it's really worth having a detailed conversation with a neurologist or headache specialist. They can help determine whether Aimovig or another CGRP-targeting treatment might be a good fit for your specific experience.
A few other CGRP options that may also be worth discussing include:
- Ajovy (fremanezumab)
- Emgality (galcanezumab)
- Nurtec ODT (rimegepant) — approved for both prevention *and* acute treatment
AI-generated responses are not a substitute for medical advice. These services are not intended to
diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.
Migraine Treatments and How They Work
May 31
Join
Your Privacy Choices
